Astellas Pharma Gets Positive Opinion From European Regulator for Advanced Gastric Cancer Drug
Astellas Pharma Gets Positive Opinion From European Regulator for Advanced Gastric Cancer Drug
安斯泰莱制药(adr)获欧洲监管机构就先进胃癌药物的积极意见。
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登录免费看全文
登录/注册